1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BEIGENE LTD - ADR
BeiGene Ltd - ADR
XNAS: ONC
Await Turnaround
Download real time
350.13-13.89(-3.82%)
37.87% Gain from 52W Low
409.0K
XNAS Volume

XNAS 08 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

BeiGene Ltd (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for BeiGene Ltd (ADR) share price target, revenues, EPS, net income and more

BeiGene Ltd (ADR) quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue BeiGene Ltd (ADR) Jun-2026 Quarterly Revenue is $1,705 Million which is growth of 29.6% YoY.

  • POSITIVE

    Quarterly Net Profit BeiGene Ltd (ADR) Jun-2026 Quarterly Net Profit is $237 Million which is growth of 151.3% YoY.

BeiGene Ltd - ADR, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Operating Rev.
1,705.11,513.41,498.21,412.31,315.31,117.31,127.8
Cost Of Rev.
174.5167.2142.4196.5164.6165160.6
Gross Profit
1,530.51,346.21,355.81,215.81,150.7952.3967.3
⌄
1,205.51,096.31,170.71,052.71,062.8941.21,046.7
Operating Profit
325.1249.9185163.187.911.1-79.4
⌄
-11.8-5.2-0.133.55.97.8
Profit Before Tax
312.5259.2149.2147.299.620.9-85.4
Tax
75.531.982.722.35.219.666.5
⌄
237227.466.5124.894.31.3-151.9
Diluted NI Avail to Com Stockholders Ann.
237227.466.5124.894.31.3-151.9
Basic EPS
2.12.10.71.20.9-1.4
Diluted EPS After ExtraOrdinary
2.120.510.8-1.4
Number Of Shares End
111.6111110.8110.2108.3106.9107
Net Income Continuing Discontinued Operations
237227.466.5124.894.31.3-151.9
Normalized Income
237227.466.5124.894.31.3-151.9
Interest Income
27.927.758.133.55.97.8
Interest
39.732.9-----
Net Interest Income
-11.8-5.2-0.133.55.97.8
EBIT
352.2292.1213163.187.911.1-79.4
EBITDA
392.7333.3249200.4123.543.9-29.2
Reconciled Cost Of Rev.
174.5167.2142.4196.5164.6132.2160.6
Reconciled Depr.
40.541.13637.335.632.850.3
Profit From Continuing Operations
237227.466.5124.894.31.3-151.9
Normalized EBITDA
392.7333.3249200.4123.543.9-29.2
*All financials are in USD Million and price data in USD
Add metric to table
Search...

BeiGene Ltd (ADR) competitor comparison and performance snapshot within industry

BeiGene Ltd (ADR) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue BeiGene Ltd (ADR) Dec-2025 Annual Revenue is $5,343 Million which is growth of 40.2% YoY.

  • POSITIVE

    Annual Net Profit BeiGene Ltd (ADR) Dec-2025 Annual Net Profit is $287 Million which is growth of 144.5% YoY.

BeiGene Ltd - ADR, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphTTMDec '25Dec '24
⌄
 5,3433,810.2
Cost Of Rev. Ann.
680.7668.5594.1
Gross Profit Ann.
5,448.34,674.53,216.2
Operating Exp. Ann.
4,525.24,227.43,784.4
Operating Profit Ann.
923.1447.1-568.2
⌄
-14.112.347.8
Other Exp. Ann.
 -42.6-12.6
PBT Ann.
868.1416.9-533
Tax Ann.
212.4129.9111.8
⌄
655.7286.9-644.8
Diluted NI Avail to Com Stockholders Ann.
655.7286.9-644.8
EPS Ann.
 2.6-6.1
Diluted EPS Ann.
 2.5-6.1
Number Of Shares End
 110.8107
Total Exp. Ann.
 4,895.94,378.4
Net Income Continuing Discontinued Operations Ann.
655.7286.9-644.8
Normalized Income Ann.
655.7286.9-644.8
Interest Income Ann.
116.770.547.8
Interest Ann.
 58.2-
EBITDA Ann.
1,175.3616.8-396.4
Reconciled Cost Of Rev. Ann.
680.7668.5594.1
Reconciled Depr. Ann.
154.9141.7171.8
Profit From Continuing Operations Ann.
655.7286.9-644.8
Normalized EBITDA Ann.
1,175.3616.8-396.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
40.2%
Operating Exp. Ann.
1Y CHG
11.7%

BeiGene Ltd (ADR) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund BeiGene Ltd (ADR) Dec-2025 Total Shareholders Fund is $4,361 Million which is growth of 30.9% YoY.

  • POSITIVE

    Total Assets BeiGene Ltd (ADR) Dec-2025 Total Assets is $8,189 Million which is growth of 38.3% YoY.

BeiGene Ltd - ADR, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphDec '25Dec '24
⌄
8,188.65,920.9
⌄
3,827.42,588.7
⌄
4,361.23,332.2
Total Capitalization Ann.
5,323.13,498.7
Tangible Assets Ann.
4,219.63,202.5
Working Capital Ann.
4,404.81,776.7
Invested Capital Ann.
5,380.44,350.2
Tangible Book Value Ann.
4,219.63,202.5
Borrowings Ann.
1,092.81,079.9
Net Debt Ann.
--
Share Issued Ann.
1,5411,384.8
Number Of Shares End
110.8107
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
38.3%
Total Current Liabilities Ann.
1Y CHG
-17.4%
Total ShareHolders Funds Ann.
1Y CHG
30.9%

BeiGene Ltd (ADR) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share BeiGene Ltd (ADR) Book Value Per Share is $39 which is growth of 14.5% YoY.

  • NEUTRAL

    ROE BeiGene Ltd (ADR) ROE is 0% which is growth of 0% YoY.

BeiGene Ltd - ADR, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphDec '25Dec '24
RoA Ann. %
--11.00%
ROE Ann. %
--18.77%
ROIC %
--3.5
OPM Ann. %
8.37%-14.91%
Inventory Turnover Ratio Ann.
-1.3
Asset Turnover Ann. %
-0.7
Working Capital Turnover Ann.
1.22.1
Quick Ratio Ann.
-1.5
Current Ratio Ann.
-1.8
Interest Coverage Ratio Ann.
--
LT Debt To Equity Ann.
-0.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...

BeiGene Ltd (ADR) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity BeiGene Ltd (ADR) Dec-2025 Cash From Operating Activity is $1,128 Million which is growth of 901.8% YoY.

  • POSITIVE

    Net Cash Flow BeiGene Ltd (ADR) Dec-2025 Net Cash Flow is $1,911 Million which is growth of 485.6% YoY.

BeiGene Ltd - ADR, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphDec '25Dec '24
⌄
1,127.6-140.6
⌄
-276.2-548.4
⌄
1,059.5193.5
Cash Plus Cash Eqv. End Of Year Ann.
4,609.72,638.8
Net Increase In Cash Plus Cash Eqv.s Ann.
1,910.9-495.5
Cash Plus Cash Eqv. Begin Of Year Ann.
2,638.83,186
Income Tax Paid Supplemental Data Ann.
-69.4
Interest Paid Supplemental Data Ann.
52.551.2
Capex Ann.
-266.5-529.1
Issuance Of Capital Stock Ann.
--
Issuance Of Debt Ann.
1,084.3877.3
Repayment Of Debt Ann.
-1,080.5-732.3
Repurchase Of Capital Stock Ann.
--
Free Cash Flow Ann.
861.1-669.8
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
447.5%
×